167 related articles for article (PubMed ID: 11232728)
1. The effect of ursodeoxycholic acid in children with prolonged hepatitis A virus infection that may be a trigger factor for autoimmune hepatitis.
Koçak N; Saltik IN
Am J Gastroenterol; 2001 Feb; 96(2):610-1. PubMed ID: 11232728
[No Abstract] [Full Text] [Related]
2. [Peripheral blood lymphocyte apoptosis in children with viral hepatites A, B, C and effect of ursodeoxycholic acid preparations].
Matanina NV; Reĭzis AR
Eksp Klin Gastroenterol; 2008; (5):106-10. PubMed ID: 19145924
[TBL] [Abstract][Full Text] [Related]
3. Re: Azathioprine monotherapy for maintenance of remission in pediatric patients with autoimmune hepatitis.
van de Nadort C; Houwen RH; Stapelbroek JM
J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):490. PubMed ID: 18030221
[No Abstract] [Full Text] [Related]
4. Prolonged cholestasis due to hepatitis A virus infection.
Kumar P; Bhatia V
Indian Pediatr; 2011 Jun; 48(6):485-6. PubMed ID: 21743116
[TBL] [Abstract][Full Text] [Related]
5. Prolonged acute hepatitis A mimicking autoimmune hepatitis.
Mikata R; Yokosuka O; Imazeki F; Fukai K; Kanda T; Saisho H
World J Gastroenterol; 2005 Jun; 11(24):3791-3. PubMed ID: 15968741
[TBL] [Abstract][Full Text] [Related]
6. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
[TBL] [Abstract][Full Text] [Related]
7. [A case of autoimmune hepatitis followed-up with an oral administration of ursodeoxycholic acid].
Sugimoto M; Saito Y; Akimoto T; Kato H; Miyashita M; Shinohara M; Shinohara M; Wakui T; Hirata A; Saito N; Nonaka H
Nihon Shokakibyo Gakkai Zasshi; 2004 Nov; 101(11):1232-7. PubMed ID: 15570873
[No Abstract] [Full Text] [Related]
8. Elevated bile acids associated with acute hepatitis A infection in the third trimester of pregnancy.
Grossmith AK; Bhatia K; Heazell AE
J Obstet Gynaecol; 2009 Jan; 29(1):54-5. PubMed ID: 19280498
[No Abstract] [Full Text] [Related]
9. Remission with ursodeoxycholic acid of type 1 autoimmune hepatitis resistant to azathioprine and steroids.
Duclos-Vallée JC; Di Martino V; Cazier A; Ballot E; Johanet C; Yamamoto AM; Emile JF; Guettier C; Coutarel P; Cadranel JF
Gastroenterol Clin Biol; 2005 Nov; 29(11):1173-6. PubMed ID: 16505766
[TBL] [Abstract][Full Text] [Related]
10. [A case of probable autoimmune hepatitis from which the persistence of hepatitis A IgM antibody, and the improvement was pathologically obtained by ursodeoxycholic acid medication].
Matsushita M; Takemura T; Imai Y; Takimoto K; Kuchide M; Kajikawa H; Kojima Y; Shimamoto F; Yamauchi H; Matsuyama K; Yoshikawa T
Nihon Shokakibyo Gakkai Zasshi; 2008 Sep; 105(9):1367-74. PubMed ID: 18772578
[TBL] [Abstract][Full Text] [Related]
11. Deflazacort for type-1 autoimmune hepatitis in a Korean girl.
Bae SH; Kim JS; Kim DH
J Korean Med Sci; 2006 Aug; 21(4):758-60. PubMed ID: 16891827
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival.
Al-Chalabi T; Portmann BC; Bernal W; McFarlane IG; Heneghan MA
Aliment Pharmacol Ther; 2008 Jul; 28(2):209-20. PubMed ID: 18433467
[TBL] [Abstract][Full Text] [Related]
13. Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis with unusual initial presentation as fulminant hepatic failure.
Kayacetin E; Köklü S; Temuçin T
Dig Liver Dis; 2004 Jun; 36(6):419-22. PubMed ID: 15248383
[TBL] [Abstract][Full Text] [Related]
14. Guidelines for therapy of autoimmune liver disease.
Ishibashi H; Komori A; Shimoda S; Gershwin ME
Semin Liver Dis; 2007 May; 27(2):214-26. PubMed ID: 17520519
[TBL] [Abstract][Full Text] [Related]
15. Non-alcoholic steato-hepatitis.
Chawla Y; Amrapurkar D
Trop Gastroenterol; 2002; 23(4):186-8. PubMed ID: 12833707
[No Abstract] [Full Text] [Related]
16. [Treatment of autoimmune hepatic diseases].
Bueverov AO
Klin Med (Mosk); 2004; 82(10):62-6. PubMed ID: 15584604
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid as a supplementary treatment in corrected biliary atresia.
Smaropoulos EC; Kaselas B
Eur J Pediatr Surg; 2006 Apr; 16(2):138-9. PubMed ID: 16685625
[No Abstract] [Full Text] [Related]
18. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.
Joshi S; Cauch-Dudek K; Wanless IR; Lindor KD; Jorgensen R; Batts K; Heathcote EJ
Hepatology; 2002 Feb; 35(2):409-13. PubMed ID: 11826416
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune hepatitis 2 years after the diagnosis of primary sclerosing cholangitis: an unusual overlap syndrome in a 17-year-old adolescent.
Mueller T; Bianchi L; Menges M
Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):232-6. PubMed ID: 18301306
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid in the management of prolonged cholestasis of acute hepatitis B.
Kadayifci A; Savas MC; Arslan S; Güllú IH
J Clin Gastroenterol; 1997 Mar; 24(2):125-6. PubMed ID: 9077736
[No Abstract] [Full Text] [Related]
[Next] [New Search]
